The role of MSCs and CAR-MSCs in cellular immunotherapy

L Yan, J Li, C Zhang - Cell Communication and Signaling, 2023 - Springer
Chimeric antigen receptors (CARs) are widely used by T cells (CAR-T cells), natural killer
cells dendritic cells and macrophages, and they are of great importance in cellular …

High-risk corneal transplantation: recent developments and future possibilities

WJ Armitage, C Goodchild, MD Griffin, DJ Gunn… - …, 2019 - journals.lww.com
Human corneal transplantation (keratoplasty) is typically considered to have superior short-
and long-term outcomes and lower requirement for immunosuppression compared to solid …

Immunomodulation of MSCs and MSC-derived extracellular vesicles in osteoarthritis

X Zhao, Y Zhao, X Sun, Y **ng, X Wang… - … in Bioengineering and …, 2020 - frontiersin.org
Osteoarthritis (OA) has become recognized as a low-grade inflammatory state. Inflammatory
infiltration of the synovium by macrophages, T cells, B cells, and other immune cells is often …

[HTML][HTML] Future directions in managing aniridia-associated keratopathy

AJH Van Velthoven, TP Utheim, M Notara… - Survey of …, 2023 - Elsevier
Congenital aniridia is a panocular disorder that is typically characterized by iris hypoplasia
and aniridia-associated keratopathy (AAK). AAK results in the progressive loss of corneal …

Decellularization and recellularization of cornea: Progress towards a donor alternative

J Fernández-Pérez, M Ahearne - Methods, 2020 - Elsevier
The global shortage of donor corneas for transplantation has led to corneal bioengineering
being investigated as a method to generate transplantable tissues. Decellularized corneas …

TGF-β1-licensed murine MSCs show superior therapeutic efficacy in modulating corneal allograft immune rejection in vivo

K Lynch, O Treacy, X Chen, N Murphy, P Lohan… - Molecular Therapy, 2020 - cell.com
Mesenchymal stromal cells (MSCs) are a promising therapeutic option for multiple immune
diseases/disorders; however, efficacy of MSC treatments can vary significantly. We present a …

TNF‐α/IL‐1β—licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell‐mediated induction of Foxp3+ regulatory T cells in the lung

N Murphy, O Treacy, K Lynch, M Morcos… - The FASEB …, 2019 - Wiley Online Library
Mesenchymal stromal cells (MSCs) have shown promise as a therapy for immune‐mediated
disorders, including transplant rejection. Our group previously demonstrated the efficacy of …

Third-party allogeneic mesenchymal stromal cells prevent rejection in a pre-sensitized high-risk model of corneal transplantation

P Lohan, N Murphy, O Treacy, K Lynch… - Frontiers in …, 2018 - frontiersin.org
High-risk cornea transplant recipients represent a patient population with significant un-met
medical need for more effective therapies to prevent immunological graft rejection due to …

Healing the Cornea: Exploring the Therapeutic Solutions Offered by MSCs and MSC-derived EVs

M Jammes, A Tabasi, T Bach, T Ritter - Progress in Retinal and Eye …, 2024 - Elsevier
Affecting a large proportion of the population worldwide, corneal disorders constitute a
concerning health hazard associated to compromised eyesight or blindness for most severe …

MSCs helped reduce scarring in the cornea after fungal infection when combined with anti-fungal treatment

Y Zhou, Y Chen, S Wang, F Qin, L Wang - BMC ophthalmology, 2019 - Springer
Abstract Background Fungal Keratitis (FK) is an infective keratopathy with extremely high
blindness rate. The damaging effect of this disease is not only the destruction of corneal …